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Fas is a 45-kD cell surface protein belonging to the tumor necrosis factor/nerve growth factor 
receptor family, and transduces the signal for apoptosis.  The cytotoxic T  lymphocyte (CTL) 
hybridoma, PC60-dl0S requires the presence of Fas on target cells to induce cytolysis in target 
ceils. This CTL cell line was weakly but specifically stained by a chimeric protein that consisted 
of the extracellular domain of mouse Fas and the Fc portion of human immunoglobulin G1 
(mFas-Fc).  Moreover, mFas-Fc inhibited the cytotoxic activity of PC60-dl0S.  Sublines of dl0S 
that were stained intensively by mFas-Fc were isolated by repetitive fluorescence-activated cell 
sorter sorting. A cell-surface protein of about 40 kD was specifically precipitated by mFas-Fc 
from the lysates of these sublines. This protein was homogeneously purified by sequential affinity 
chromatographies using mFas-Fc and concanavalin A beads. The purified protein exhibited cytotoxic 
activity against cells expressing Fas but not to the cells which do not express Fas. These results 
indicated that the 40-kD membrane glycoprotein expressed on PC60-dl0S cells is the Fas-ligand 
that induces the apoptotic signal by binding to Fas. 
H 
omeostasis in mammals is controlled not only by cell 
proliferation and differentiation but also by cell death. 
Once a cell is destined to die, a programmed death process 
occurs in the cell. Apoptosis is a morphologically defined death 
process often associated with programmed cell death during 
the normal development of multicellular organisms (1-3). 
Apoptotic cell death has also been identified in other types 
of cell death, which include cytolysis induced by TNF/lym- 
photoxin (LT) t or some cytotoxic T  cells (4,  5). 
The Fas antigen (Fas) is a 45-kD cell-surface protein be- 
longing to  the TNF/nerve growth factor (NGF) receptor 
family that includes two TNF receptors (TNFR~,  type I 
or p55;  TNFRot,  type II  or p75),  the low-affinity NGF 
receptor, and the CD40, CD27, CD30, and OX40 (6). Some 
mAbs recognizing Fas induce apoptotic cell death in cells 
expressing Fas (7, 8). These facts suggest that Fas is a receptor 
for a death factor (6). 
Both lymphoid and nonlymphoid cells, as well as normal 
and transformed cell lines, are susceptible to the cytolytic ac- 
tivity of agonistic anti-Fas mAbs (anti-Fas or anti-APO-1 anti- 
bodies) (8-12).  We have shown that various tissues induding 
the thymus, heart, lung, liver, and ovary express the Fas mRNA 
(13). These results suggest that Fas is involved in many aspects 
1 Abbreviations used in this paper: LT, lymphotoxin; PVDF, polyvinyldi- 
fluoride; TBS, Tris-buffered  saline. 
of apoptotic cell death, including those that occur in normal 
development, homeostasis, and tumor regression. 
In recent reports, we and others have suggested that Fas 
plays important roles especially in the immune system. We 
have demonstrated that the mouse lymphoproliferation (Ipr) 
mutation that causes abnormal T cell development and SLE- 
like autoimmune disease, is a mutant of Fas gene (14). This 
discovery, together with the facts that thymocytes from wild- 
type mice express Fas and are susceptible to anti-Fas  mAb 
(12), suggests that Fas is involved in T  cell development in 
the thymus. Fas is also expressed on human peripheral ma- 
ture T  cells, which acquire susceptibility to anti-Fas mAbs 
in culture in vitro (11). These results and a report that ma- 
ture T  cells of lpr mice have a defect in antigen-stimulated 
suicide (15), imply a role for Fas in the peripheral tolerance 
of mature T cells. Recently, Rouvier et al. (16) demonstrated 
that the CTL hybridoma PC60-dl0S (dl0S) and allospecific 
CTL derived from peritoneal exudate lymphocytes require 
the expression of Fas on target cells to induce their Ca  2+- 
independent cytotoxicity. These results suggested the expres- 
sion of the Fas-ligand on the surface of dl0S cells, and a role 
for the Fas-ligand as an important effector molecule involved 
in T cell-mediated cytolysis. To confirm the presence of the 
Fas-ligand on dl0S cells, and if so confirmed, to isolate and 
characterize it, we here constructed a soluble fusion protein 
that consisted of the extracellular region of Fas and the Fc 
region  of  human  IgG1  (mFas-Fc).  Using  mFas-Fc,  we 
identified and purified a 40-kD membrane glycoprotein that 
can specifically induce cytolysis in cells expressing Fas. 
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Cell Lines 
A CTL hybridoma cell line, PC60-dl0S (16) and its sublines were 
maintained in DMEM (Nissui, Tokyo, Japan) supplemented with 
10% FCS, 50 nM 2-ME, and 100 U/ml benzylpenicillin potassium 
(Meiji Seika Co., Ltd., Tokyo, Japan) plus 100 ~g/ml streptomycin 
sulfate (P+S; Meiji Seika Co.). WR19L and its mouse Fas cDNA 
transfectant (W4)  (12) were maintained in RPMI 1640 medium 
(Nissui) supplemented with 10% FCS and P+ S. BTS-1 (17), a trans- 
fectant of BSC-40 carrying a temperature-sensitive SV40 large T 
antigen gene, was maintained in DMEM (high glucose type; Nikken 
Biomedical Lab., Tokyo, Japan) supplemented with 10% FCS, an 
extra 0.6% glutamine, and P+S. All cells were cultured in a hu- 
midified atmosphere containing  5%  CO2  at  37~  except that 
BTS-1 was maintained  at 39.5~ 
Construction of Expression Plasmids for Fusion Proteins 
An expression plasmid for mFas-Fc was constructed as follows. 
A pair of oligonucleotide primers containing a sense sequence in 
intron 4 (GATTTTCAACCACTCAGTCG) and an antisense se- 
quence in intron 5 of the mouse Fas gene (GCTGGATCCTTTG- 
TATGAAATTGAGTAAT) were synthesized. The latter oligonu- 
cleotide  contains  a  BamHI site  at  its  5'  end.  A  383-bp  DNA 
fragment containing exon 5, and its 5' and 3' flanking regions was 
amplified by PCR from a plasmid harboring the mouse Fas chro- 
mosomal gene (Watanabe-Fukunaga,  R., and S. Nagata, unpub- 
lished results)  using the  above primers.  The PCR product  was 
digested at the PstI site in exon 5 and at the BamHI site in the 
antisense primer. The 128-bp PstI-BamHl fragment containing the 
3' end of exon 5 and part of intron 5 was used to replace the PstI- 
BamHI DNA  fragment of pMF1  (13)  to  generate  the  plasmid 
pMFX. The plasmid pMH4 carries exons for the human IgG1 H 
chain constant region (18). The 1.7-kb HaelI DNA fragment of 
the plasmid pMH4 was subcloned into the XbaI site of pBluescript 
KS(+) (Stratagene, La Jolla, CA). The 1.4-kb HinclI-ApaI DNA 
fragment containing the exons for the hinge, CH2, and CH3 do- 
mains was inserted into the XbaI site os pMFX to produce pFAS- 
Fc. The 2.3-kb KpnI-NotI DNA fragment of pFAS-Fc was ligated 
into  the  mammalian expression  vector pEF-BOS  (19),  and  the 
resulting plasmid was designated pFAS-FclI. To construct an ex- 
pression plasmid (hTNFRB-Fc) for a chimeric protein consisting 
of the extracellular region of human TNFR/~ and the Fc region 
of human IgG1 (nTNFR~Fc), the 0.7-kb HinclI~  fragment 
of pFAS-FclI carrying the extracellular region of Fas was replaced 
with the 650 bp of the KpnI-HindlII fragment of p55TNFr-HG1 
that contains the cDNA sequence for the extracellular region of 
the human TNFR,8, followed by an artificial splice donor sequence 
(20). 
Production of mFas-Fc and hTNFRfl-Fc 
COS cells were transfected using the DEAE-dextran method 
as described (21). The transfected cells were successively incubated 
for 24 h in medium containing 10%  FCS,  then for 48 and 72 h 
in serum-free medium. The serum-free supernatant was combined, 
centrifuged,  and passed through a 0.45-#m filter to remove cell 
debris. To produce the chimeric molecules in BTS-1 cells (17), stable 
transformants carrying the expression plasmids were established 
by transfecting BTS-1 by means of electroporation (22).  In brief, 
107  cells  were  transfected  with  50  /~g  of  the  plasmid  DNA 
digested with ApaLI for pFAS-FclI or SacI for pTNFR~-Fc, and 
5/~g of XhoI-digested pSTneoB.  After selection in DMEM con- 
taining  10%  FCS and 300 ~g/ml of G-418  for 10 d,  individual 
G-418-resistant colonies were isolated and grown at 39.5~  To 
identify the clones that produce the chimeric molecules, aliquots 
of cells were cultured at 33~  for 3 d, and the chimeric proteins 
secreted  into the medium were assayed by ELISA using purified 
goat anti-human IgG-Fc antibodies (Cappel, Durham, NC) as cap- 
ture  antibodies,  and  horseradish  peroxidase-conjugated  goat 
anti-human IgG-Fc antibodies (Jackson ImmunoResearch, West 
Grove, PA) as detection antibodies. One transformant that efficiently 
produces the chimeric molecule was selected for each mFas-Fc and 
hTNFRB-Fc, and expanded at 39.5~  To generate culture super- 
natants containing chimeric proteins,  the transformants were plated 
on 10-cm  dishes  at "~50% confluence and cultured for 1 wk at 
33~  The  chimeric  molecules  were  purified  on  a  protein 
A-Sepharose CL4B column  (Pharmacia,  Uppsala,  Sweden),  and 
their protein concentration was estimated by measuring the OD 
at 280 nm based on the assumption that OD of 1.4 corresponds 
to  1 mg/ml. 
Flow Cytometric Analysis and Cell Sorting 
The mFas-Fc was biotinylated using sulfosuccinimidyl 6-(bio- 
tinamido) hexanoate (NHS-LC-biotin; Pierce,  Rockford, IL) ac- 
cording to the manufacturer's protocol. To prepare FITC-conjugated 
hTNFR~8-Fc, 1 mg of protein was mixed with 20/~g of FITC in 
1 ml of 50 mM sodium carbonate buffer (pH 9.5). After an incuba- 
tion  at  room temperature for 4  h,  free FITC was removed by 
Sephadex G-25M column chromatography.  For flow cytometry, 
r~106 cells  were  first  incubated  on  ice for  10  rain  in  50  ~1  of 
staining buffer (PBS containing 2% FCS and 0.02%  NAN3) con- 
taining 5/~g/ml rat anti-mouse Fc34I  receptor antibody (Phar- 
Mingen, San Diego, CA). 50 #1 ofbiotinylated mFas-Fc (10/~g/ml) 
was added to the mixture, and incubated on ice for 30 min. After 
washing with staining buffer, the cells were stained on ice for 30 
min with PE-conjugated  streptavidin (25-fold dilution;  Becton Dick- 
inson & Co.,  Mountain View,  CA) in  100/~1 of staining buffer. 
Ceils were then washed with staining buffer and analyzed using 
a FACScan |  (Becton Dickinson). 
A subpopuhtion of dl0S cells that stained intensely with mFas-Fc 
was selected by repetitive FACS  |  sorting. In brief,  1-3  x  107 dl0S 
cells were stained with FITC-conjugated hTNFRB-Fc and biotinyl- 
ated mFas-Fc followed by PE-streptavidin as described above (except 
that the staining buffer did not contain NAN3), and sorted using 
a FACStar |  (Becton Dickinson). Cells providing the highest levels 
of PE-fluorescence  signal (top 0.3-0.5%), but without significant 
FITC-hTNFRB-Fc staining, were collected and expanded in DMEM 
containing  10%  FCS and 50 nM 2-ME. 
Cytotoxicity Assay 
Cytotoxicity was assayed essentially as described previously (16). 
WR19L or W4 cells (10 6 cells) were incubated for 2 h  at 37~ 
with 20 #Ci of [51Cr] sodium chromate (Amersham, Bucks,  UK) 
in 100 #1 of RPMI 1640 containing 10% FCS. After washing with 
medium, these cells were used as targets. The SlCr-labeled  target 
cells (l& cells/well)  were mixed with dl0S or its derivatives at var- 
ious ratios in round-bottomed microtiter plates in a total volume 
of 200 #1. The plates were centrifuged at 80 g for 2 rain, and in- 
cubated for 4 h at 37~  The plates were then centrifuged at 250 
g for 5 min, and 100/xl aliquots of the supernatants were assayed 
for radioactivity using a "/-counter.  The spontaneous release  of 
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alone,  whereas the maximum release  was determined by adding 
Triton X-100 to a final concentration of 0.1%. The percent specific 
lysis was calculated  as follows:  [(experimental 51Cr release  -  spon- 
taneous 51Cr release)/(maximum S:Cr release  -  spontaneous SlCr 
release)]. 
Biotinylation of Cell Surface Proteins 
Cell surface proteins were biotinylated as described previously 
(23). Briefly, cells (107 cells/ml) were suspended in 10 mM sodium 
borate (pH 8.5), and 150 mM NaC1 containing 50/zg/ml of NHS- 
LC-biotin. After an incubation at room temperature for 15 min, 
the reaction was stopped by adding a final concentration of 10 mM 
NH4C1,  then washed three times with Tris-buffered saline (TBS; 
50  mM Tris-HC1, pH 8.0,  150 mM  NaC1). 
Preparation of mFas-Fc Affinity Column 
4 mg of the purified mFas-Fc in 4 ml PBS (pH 7.4) was mixed 
with 2 ml of protein A-Sepharose CL4B beads and allowed to bind 
for 1 h  at 4~  The beads were washed three times with  TBS, 
then once with 200 mM sodium borate (pH 9.0) to remove free 
proteins. The bound mFas-Fc was covalently conjugated to the beads 
by an incubation in 200 mM sodium borate (pH 9.0) containing 
dimethylpimerimidate (DMP)  for 45  rain  at room temperature. 
Purification of Fas-Ligand 
Large Scale Culture.  The Fas-ligand was purified from the sorted 
sublines of PC60-dl0S (sorted 8-12 times). The cells were cultured 
in 10 roller bottles (Coming, Inc., Coming, NY) containing 500 
ml/bottle of 10% FCS-DMEM supplemented with 50 nM 2-ME 
and 20 mM Hepes (pH 7.4), and placed on a roller (ROLLACELL; 
New Brunswick  Scientific,  NJ) in a conventional atmosphere at 
37~  When the cell concentration reached ,~2  x  105 ceUs/ml, 
10 ng/ml of PMA and 500 ng/ml of ionomycin were added to the 
culture and incubated for another 4 h.  The cells were then har- 
vested by centrifugation  at 250 g  for 20 min,  and washed three 
times with PBS and once with TBS.  The cells were pelleted and 
stored at  -80~  until they were used to prepare the membrane 
fraction. One batch of cells (~10  9 cells)  was surface biotinylated 
as described above. 
Solubilization of the Membrane Fraction.  The frozen cell pellet 
(7.5  ml,  •109  cells)  was  disrupted  in  four volumes  (30  ml) of 
0.3 M sucrose containing 1 mM (paminophenyl) methanesulfonyl 
fluoride  hydrochloride  (APMSF),  1  #g/ml  pepstatin,  1  #g/ml 
leupeptin, and 0.02% NaN3 using an Ultra-Turrax T25 (Janke & 
Kunkel, Staufen, Germany) at the blue position for 2 min on ice, 
and centrifuged at  1,000 g  for 20  min at 4~  to remove nuclei 
and unbroken cells. The supernatant was centrifuged at 100,000 g 
for 90 min at 4~  to obtain the membrane-enriched fraction. The 
pellet was dissolved  in 40 ml of lysis buffer (TBS containing 1% 
NP-40, 1 mM APMSF,  1/zg/ml pepstatin, and 1 #g/ml leupeptin), 
and rocked overnight at 4~  The solubilized membrane fraction 
was obtained by centrifugation at  100,000  g  for 60 rain at 4~ 
and stored at  -  80~  Surface biotinylated cells were processed simi- 
larly and stored at  -80~  as 10-ml aliquots. 
Affnity Purification  Using mFas-Fc  Column and Con A Beads.  As 
a tracer for the Fas-ligand, 10 ml of the solubilized membrane pro- 
teins from the biotinylated cells were added to 100 ml of the pooled 
solubilized crude membrane fraction. The mixture was applied to 
a 1.4 ml mFas-Fc affinity column equilibrated with TBS containing 
1% NP-40, and the flow-through fraction was applied once more 
to the same column. The column was washed with 50 ml of TBS 
containing 1% NP-40, then with 50 ml of TBS containing 0.1% 
NP-40. The Fas-ligand bound to the column was eluted by 50 mM 
Tris-HC1 buffer (pH 8.0) containing 1 M NaC1 and 0.1% NP-40. 
Fractions of I  ml were collected,  and 10 #1 of each was resolved 
by SDS-PAGE,  then transferred to a polyvinyldifluoride (PVDF) 
membrane. Biotinylated  proteins were stained with horseradish  per- 
oxidase-conjugated streptavidin and detected using the ECL (en- 
hanced chemiluminescence) system (Amersham) according to the 
manufacturer's  protocol.  Fractions  containing  the  40-kD  bi- 
otinylated Fas-ligand were pooled and incubated with 10 #1 of Con 
A-agarose beads (E.Y Laboratories, San Mateo, CA) overnight at 
4~  After washing four times with TBS containing 0.1% NP-40, 
the Fas-ligand  was eluted from the beads in 200 #1 of PBS con- 
taining 0.1%  NP-40 and 2  M  c~-methylmannoside. 
Results and Discussion 
Production and Purification of mFas-Fc  and hTNFRfl-Fc.  Re- 
cently, several groups have successfully used chimeric molecules 
consisting of the extracellular region of the receptor and the 
Fc portion of human IgG1 to identify the ligand for orphan 
receptors  (24,  25).  To identify  the  Fas-ligand,  a  similar chi- 
meric molecule was constructed by fusing the extracellular re- 
gion of mouse Fas to the Fc region of human IgG1. As a con- 
trol,  a  soluble form of human TNF  receptor (hTNFR~-Fc) 
was  constructed  by  a  similar  method.  The  mFas-Fc  and 
hTNFR3-Fc  chimeric molecules were transiently produced 
in COS cells, or in a stable BTS-1 transformant.  These chi- 
meric molecules were purified by protein A  affinity chroma- 
tography. When the purified mFas-Fc and hTNFR/3-Fc were 
analyzed by SDS-PAGE, major bands at 55 and 60 kD were 
observed, respectively, under reducing conditions,  and  ll0- 
and 140-kD bands were apparent under nonreducing condi- 
tions (Fig.  1). These results indicated that both mFas-Fc and 
hTNFR3-Fc  existed mainly  as dimers. 
Figure  1.  Analysis  of the purified mFas-Fc and hTNFR3-Fc by SDS- 
PAGE. 2/~g of the purified mFas-Fc (lanes I and 3) or hTNFR3-Fc (lanes 
2 and 4) were separated on a gradient PAGE (4-20%)  in the presence of 
0.1% SDS under nonreducing (lanes I and 2) or reducing conditions (lanes 
3 and 4), and stained  by Coomassie  brilliant blue. Molecular  weight markers 
(kD) (Rainbow markers, Amersham) are shown on the left. 
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Figure 2.  The Fas-dependent  cytotoxic  activity  of 
dl0S cells and its inhibition by mFas-Fc. (a) The cyto- 
toxic activity of dlOS cells against W4 (e, &) or 
WR19L cells (O, A) was assayed as described in 
Materials and Methods in the presence  (A, A) or ab- 
sence (e, O) of PMA (10 ng/ml) and ionomycin (3 
/xg/ml). (b)  Indicated doses of mFas-Fc (e),  bi- 
otinylated mFas-Fc  (A), hTNFR3-Fc  (A), human IgG 
(Zymed Laboratories, S. San Francisco, CA) (O) were 
added to the assay mixture containing 2 x  10  s dl0S 
cells and 104 W4 cells (E/T  =  20). 
Expression of the Fas-ligand on the Cell Surface of dlOS.  Pre- 
viously, Kouvier et al. (16) reported that the cytotoxic T cell 
line dl0S requires expression of Fas on target cells for their 
cytolysis. These results were confirmed using W4, a cell line 
transfected with mouse Fas cDNA and its parental cell line, 
WP,19L. As shown in Fig. 2 a, dl0S specifically induced cy- 
tolysis in W4 but not in WK19L cells.  This cytotoxic ac- 
tivity  of dl0S  cells  was  inhibited  by mFas-Fc  in  a  dose- 
dependent manner, whereas neither the purified human IgG 
nor hTNFR/3-Fc affected the cytotoxicity of dlOS cells (Fig. 
2 b). A  simple explanation  of these results is that  mFas-Fc 
bound to the Fas-ligand  expressed on dl0S cells, and inhibited 
the interaction between the Fas on W4 cells and the Fas-ligand. 
To examine whether  dl0S cells  actually express the Fas- 
ligand, dl0S cells were analyzed by flow cytometry using the 
biotinylated mFas-Fc. The mFas-Fc was biotinylated as de- 
scribed in Materials and Methods, and the biotinylated mFas-Fc 
retained activity similar to the unbiotinylated mFas-Fc in the 
cytotoxicity inhibition  assay (Fig. 2 b). As shown in Fig. 3 
a, dl0S cells were weakly but significantly stained with the 
biotinylated mFas-Fc followed by PE-conjugated streptavidin. 
The binding of the biotinylated mFas-Fc to dlOS cells was 
specific because it was blocked by unlabeled mFas-Fc but not 
by hTNFRB-Fc (data not shown). As reported previously (16), 
the cytotoxic activity of dl0S cells was enhanced by stimula- 
tion with PMA and ionomycin (Fig.  2 a). Correspondingly, 
flow cytometry indicated that the expression levels of the Fas- 
ligand on dlOS cells were enhanced by culturing the cells for 
3 h  in  the presence of PMA and ionomycin (Fig.  3 a). 
Establishment of dlOS Sublines Expressing High Levels of the 
Fas-ligand.  To characterize the Fas-ligand biochemically, we 
first established sublines of dl0S expressing the higher levels 
of the Fas-ligand.  The dlOS cells were stained with the bi- 
otinylated mFas-Fc followed by PE-conjugated streptavidin, 
and sorted using a FACStar  |  To exclude the possibility of 
enriching  the Pc'), receptor-positive population,  cells were 
also stained with FITC-conjugated hTNFRB-Fc. A cell popu- 
lation ('x,0.3-0.5% of the total),  which stained intensely with 
mFas-Fc but not with hTNFR./$-Fc,  was sorted. These cells 
were expanded in culture and then sorted again.  This cycle 
of sorting and expansion was repeated 16 times. The staining 
intensity of sorted cells by mFas-Fc was gradually increased, 
and after the 16th sorting, clones expressing the highest levels 
of Fas-ligand were isolated by limiting dilution. One cell line, 
d10S16-2, exhibited about a 120-fold-higher mean staining 
intensity compared with the original dl0S cells (Fig. 3). Cor- 
respondingly,  d10S16-2  cells  were  about  100  times  more 
efficient to induce 50%  specific lysis of W4 cells compared 
with the original dl0S cells based on the E/T ratio (Fig. 4 
a). Stimulation of d10S16-2 cells with PMA and ionomycin 
resulted in about a twofold increase of mean staining inten- 
sity with mFas-Fc (Fig. 3 b), but little enhancement of the 
cytotoxic activity of d10S16-2 was observed by this treatment 
(Fig.  4 a). 
Neither Rouvier et al. (16) nor we could detect any cyto- 
toxic activity in the culture supernatant of the original dl0S 
cells (Fig. 4 b). However, when the medium conditioned with 
d10S16-2 cells for 24 h was assayed for the cytotoxic activity, 
it showed a significant activity against W4 cells but not against 
WR19L cells  (Fig.  4 b). Addition  of PMA and ionomycin 
during the last 4 h of the culture resulted in an approximately 
threefold increase of the cytotoxic activity in the culture su- 
pernatant.  These observations indicate that the Fas-ligand can 
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Figure  3.  Flow  cytometric  analysis for Fas-ligand  expression on origanal 
dlOS and d10S16-2 cells. The dl0S (a) and d10S16-2 cells (b) were stained 
with biotinylated mFas-Fc followed  by PE-streptavidin before (gray  area) 
or after (dark  area) stimulation with PMA (10 ng/ml) and ionomycin (500 
ng/ml) for 4 h, and analyzed  by flow  cytometry.  The profiles  of cells stained 
with steptavidin-PE alone are also shown (unfilled  area). 
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Figure 4.  Cytotoxic  activity  of  original  dl0S and d10S16-2. 
The dl0S (e,  O)  or d10S16-2 cells (A,  A) (2.5  x  10  s 
cells/ml)  were  cultured  for a total of  24 h in 10% FCS-DMEM. 
Cells were cultured in the presence (O, A) or absence (e, 
A) of PMA (10 ng/ral) and ionomycin  (500 ng/ml) during 
the last 4 h of the culture period. The culture supernatant 
was concentrated  eightfold, and passed through a nitrocellu- 
lose filter.  The cytotoxic  activity  of the cells (a) or the culture 
supernatants (b) was assayed as described in Materials and 
Methods. Onefold concentration  (b) corresponds to the neat 
culture supernatant. 
be released into extracellular fluid as an active death factor 
probably by shedding, when expressed at high levels in the cells. 
Purification of the Fas-ligand.  The Fas-ligand expressed in 
the sorted subline of dl0S cells was then characterized by im- 
munoprecipitation using mFas-Fc. In Fig. 5, the d10S-12 cells 
(sorted four times) were surface biotinylated, and immuno- 
precipitated as described in Materials and Methods. An analysis 
Figure 5.  Immunoprecipitation  of the Fas-hgand.  About 107 d10S4 cells 
(sorted four cycles)  were surface  biotinylated,  then lysed  with 1 ml of  lysis 
buffer  (see  Materials  and Methods)  on ice for 30 rain. After centrifugation 
at 14,000 rpra for 15 rain, the supernatant  was precleared  by incubation 
with 50 gl of protein A-Sepharose CL4B beads for 60 rain at 4~  After 
centrifugation,  the supematant  was divided  into four portions, and incubated 
with either 10 #1 of hTNFRB-Fc (lane 1) or raFas-Fc (lanes 2 and 4) for 
30 min at 4~  foUowed  by incubation  with 10 gl of protein A-Sepharose 
CL4B beads overnight at 4~  or directly  incubated with raFas-Fc-con- 
jugated protein A-Sepharose beads (lane 3). The beads were extensively 
washed with 1% NP40-TBS, then boiled in 20 gl of sample buffer for 
SDS-PAGE. The samples  were analyzed  on gradient (10-20%) SDS-PAGE 
under reducing (lanes 1-3) or nonreducing  conditions (lane 4). The pro- 
teins were transferred to PVDF membranes (MiUipore, Bedford, MA), 
probed with horseradish  peroxidase-conjugated  streptavidin, and visual- 
ized by the ECL system.  Biotinylated  molecular  weight markers (Pierce) 
and Rainbow markers were used in the left and right panels, respectively, 
and are shown (kD). 
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of the immunoprecipitates  by SDS-PAGE  showed  a broad 
band(s)  at  '~40 kD under both reducing and nonreducing 
conditions (Fig. 5, lanes 2 and 4). Such bands were not ob- 
served when the immunoprecipitation was carried out with 
hTNFR~-Fc (Fig. 5, lane 1) or human IgG (data not shown). 
To prepare a mFas-Fc affinity column, mFas-Fc was cova- 
lently conjugated to protein A-Sepharose beads using DMP. 
Immunoprecipitation with this conjugate confirmed that it 
can efficiently bind to the Fas-ligand (Fig.  5, lane 3).  As a 
starting  material  for  purification  of  the  Fas-ligand,  total 
5  x  109 cells of dl0S sublines (sorted 8-12 times) were ob- 
tained from 25 liters of culture. One tenth of the cells was 
surface biotinylated to monitor the purification steps.  The 
plasma membrane-enriched fraction was prepared by homo- 
genization in a hypotonic buffer and differential centrifuga- 
tion,  and was  solubilized with  1%  NP40.  The  Fas-ligand 
was purified from the lysates by sequential affinity chroma- 
tography using mFas-Fc column and Con A-agarose beads 
as described in Materials and Methods.  When the purified 
proteins eluted from the Con A beads were analyzed by SDS- 
PAGE under reducing conditions, they showed a single major 
band at the position of *40 kD, both by silver staining for 
the total proteins and by the ECL system for the biotinylated 
proteins (Fig. 6 a). The faint band at the 30-kD position de- 
tected only by silver staining is probably Con A  that leaked 
from the beads. Since the silver-stained band shown in Fig. 
6 a amounted to ",d0 ng, the total recovery of the "~40-kD 
purified glycoprotein (gp 40) from 5  x  109 cells was about 
0.4  #g  or  10 pmol. 
To confirm that the purified gp40 is the Fas-ligand,  the 
cytotoxic activity of the protein was assayed using W4 and 
WR.19L cells. As shown in Fig.  6  b,  the purified gp40 in- 
duced  cytolysis in  W4  cells  in  a  dose-dependent  manner, 
whereas no cytotoxicity was observed against WR19L. When 
one unit of the Fas-ligand was defined as the amount of the 
protein required to induce a half-maximal response (40% cell 
lysis in Fig. 6  b) with W4 cells, the specific activity of the 
purified Fas-ligand was  calculated  at  ",,6.5  x  106  U/mg. 
This value nearly corresponds  to the value reported for the 
purified TNFot  (26). Figure 6.  Characterization  of the purified  Fas- 
ligand. (a) Analysis  of the purified  Fas-ligand  on 
SDS-PAGE. The purified  Fas-ligand  was analyzed 
on a 10-20% gradient PAGE in the presence of 
0.1% SDS. Proteins were either stained using a 
silver staining  kit (Wako, Tokyo,  Japan) (lane I), 
or visualized  using the ECL system  after  blotting 
onto a PVDF  membrane  (lane  2). Molecular  weight 
markers are Rainbow  markers  (left)  and biotinylated 
molecular weight markers (right) and are shown 
in kD. (b) The cytotoxic  activity  of the purified 
Fas-ligand. 51Cr-labeled  W4 (Q) or WR19L cells 
(O) (104 cells/well)  were cultured with various 
doses of the  purified Fas-ligand in  a  round- 
bottomed 96-well plate for 4 h. 
In this report, we have shown that the CTL cell line dl0S 
expresses the Fas-ligand.  We developed  a simple procedure 
to purify the Fas-ligand.  The purified Fas-ligand (gp40) had 
a cytolytic activity against the cells expressing Fas. The inhi- 
bition of the cytotoxic activity of dl0S by the soluble Fas, 
and the ability of the purified Fas-ligand to induce the cytol- 
ysis indicate that interaction of the Fas-ligand with the Fas 
on the target cells is the only condition necessary for target 
cell lysis, and that no other molecule expressed on dl0S cells 
is essentially required.  The fact that the cytotoxic activity 
increased in parallel to the increase of the Fas-ligand expres- 
sion in the sorted dl0S cells  supports this conclusion. 
Various molecules such as perforin, lymphotoxin, and TNF 
are known to be involved in the CTL-mediated cytolysis (27). 
Unlike the Fas system, the cytotoxicity of perforin is Ca  2+ 
dependent. Although TNF and LT show the Ca  2  +-indepen- 
dent cytotoxicity, the relative molecular mass of the membrane- 
bound TNF (26 kD)  (28) and the subunit structure of the 
LT (33 and 25 kD) (29) are different from those of the Fas- 
ligand. These results rule out the possibility that the Fas-ligand 
is perforin, TNF,  or LT, 
The Fas-dependent cytotoxicity  has been observed not only 
in  the CTL cell  line dl0S but  also  in Ca2+-independent, 
alloantigen-specific  CTL (16). Thus, it is likely that Fas/Fas- 
ligand system is widely used in common for CTL. We previ- 
ously demonstrated that administration of agonistic anti-Fas 
antibodies into mice killed the mice within several hours by 
inducing severe destruction of hepatocytes as seen in fulminant 
hepatitis (12). The class I MHC-restricted CTL are suggested 
to be involved in the hepatitis caused by hepatitis B virus 
(HBV) (30).  Taken together, it is possible  that the interac- 
tion of CTL specific for the HBV antigen with the HBV- 
infected hepatocytes induces the expression of the Fas-ligand 
on their surface, and that the Fas-ligand on the CTL then 
binds to Fas on hepatocytes, and induces apoptosis in hepato- 
cytes. If  so, a soluble form of human Fas or antagonistic anti- 
bodies against Fas or Fas-ligand may be used to treat patients 
during the acute phase of fulminant hepatitis.  Further ex- 
periments will aim at testing these possibilities. 
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